|
Real-time Estimate
Cboe BZX
04:50:42 03/10/26 am AEST
|
5-day change | 1st Jan Change | ||
| 8.980 USD | +0.45% |
|
+7.54% | -68.85% |
| 15/09 | Capricor Therapeutics Shares Rise After Upgrade From B. Riley | MT |
| 14/09 | B. Riley Upgrades Capricor Therapeutics to Buy From Neutral, Raises Price Target to $21 From $5 | MT |
| Market Cap | 520M 462M 431M 393M 741M 49.97B 748M 5.22B 2.02B 25.54B 1.95B 1.91B 81.98B | P/E 2026 * |
-4.87x | P/E 2027 * | -6x |
|---|---|---|---|---|---|
| Enterprise Value | 520M 462M 431M 393M 741M 49.97B 748M 5.22B 2.02B 25.54B 1.95B 1.91B 81.98B | EV / Sales 2026 * |
9.33x | EV / Sales 2027 * | 9.19x |
| Free-Float |
90.56% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CAPR | Delayed | |
CBOE
| CAPR | Real-time | |
|
Tradegate
| 4LN2 | Real-time | |
|
Börse Stuttgart
| 4LN2 | Delayed | |
|
Boerse Muenchen
| 4LN2 | Real-time | |
|
Deutsche Boerse AG
| 4LN2 | Delayed |
Last Transcript: Capricor Therapeutics, Inc.
| 1 day | -0.62% | ||
| 1 week | +6.22% | ||
| Current month | -6.23% | ||
| 1 month | -10.21% | ||
| 3 months | -61.74% | ||
| 6 months | -72.35% | ||
| Current year | -69.23% |
| 1 week | 8.15 |  | 10.72 |
| 1 month | 8.15 | | 10.72 |
| Current year | 2.96 | | 36.82 |
| 1 year | 2.96 | | 40.37 |
| 3 years | 2.68 | | 40.37 |
| 5 years | 2.56 | | 40.37 |
| 10 years | 0.88 | | 42.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Linda Marbán
CEO | Chief Executive Officer | 62 | 20/11/2013 |
Anthony Bergmann
DFI | Director of Finance/CFO | 40 | 01/01/2018 |
Michael Binks
CTO | Chief Tech/Sci/R&D Officer | - | 13/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Frank Litvack
CHM | Chairman | 70 | 01/11/2013 |
David Musket
BRD | Director/Board Member | 68 | 20/11/2013 |
George Dunbar
BRD | Director/Board Member | 79 | 20/11/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 26/5/26 | Free | CHIEF COMMERCIAL OFFICER | 80,000 | 0.1383% | ||
| 18/5/26 | Exercice | Chief Financial Officer | 6,000 | 0.0104% | ||
| 13/5/26 | Exercice | Chairman | 7,874 | 0.0136% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.62% | +6.22% | +11.42% | +198.99% | 520M | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.41B | |
| -3.11% | -3.53% | +21.92% | +74.60% | 59.26B | |
| +0.89% | -0.63% | +4.28% | +34.51% | 47.14B | |
| -1.14% | -4.74% | +26.04% | +32.85% | 42.91B | |
| +0.30% | +0.76% | +351.90% | +689.15% | 44.13B | |
| -1.50% | -2.05% | +2.40% | +98.01% | 40.79B | |
| -0.54% | +2.93% | +9.50% | +50.41% | 30.77B | |
| -2.68% | +5.11% | +33.11% | +19.50% | 29.31B | |
| +0.46% | -7.32% | -28.53% | +330.47% | 23.71B | |
| Average | -0.38% | -0.15% | +48.14% | +162.26% | 39.3B | |
| Weighted average by Cap. | -0.04% | -0.40% | +57.29% | +149.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 55.69M 49.48M 46.18M 42.09M 79.39M 5.35B 80.13M 559M 217M 2.74B 209M 205M 8.78B | 56.54M 50.23M 46.89M 42.73M 80.6M 5.44B 81.35M 567M 220M 2.78B 212M 208M 8.92B |
| Net income | -132M -117M -109M -99.76M -188M -12.69B -190M -1.32B -513M -6.49B -496M -485M -20.82B | -89.51M -79.53M -74.23M -67.66M -128M -8.6B -129M -898M -348M -4.4B -336M -329M -14.12B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/10/26 | USD 8.980 | +0.45% | 1,707,529 |
| 01/10/26 | USD 8.940 | -5.60% | 3,875,878 |
| 30/09/26 | USD 9.470 | +10.50% | 20,566,626 |
| 29/09/26 | USD 8.570 | -1.61% | 2,674,690 |
| 28/09/26 | USD 8.710 | +4.19% | 2,097,251 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CAPR Stock
Select your edition
All financial news and data tailored to specific country editions
